CANbridge Forms Rare Disease Drug Partnership with WuXi Biologics

Life Science

China Everbright Raises $155 Million for Third Life Science Fund

Life Science

LSK BioPharma and Jiangsu Hengrui Medicine Announce Global Clinical Collaboration to Evaluate the Combination of Anti-Angiogenesis and Immuno-Oncology Therapy for Patients with Advanced Hepatocellular Carcinoma (HCC)

Life Science

Reistone of Shanghai Approved for US Phase II Trial of UC Treatment

Life Science

Zai Lab Ok’d to Launch PARP Inhibitor in Hong Kong

Life Science

Gene Therapy, Gene Editing and Immuno-Oncology Creating Thousands of New Job Opportunities

Life Science

Genecast Acquires China Rights to Tumor Test from Cancer Genetics

Life Science

Ascletis’s Second HCV Treatment on Priority Review List in China

Life Science

iAnthus & MPX Bioceutical Merge to Expand Footprint into 10 States

Cannabis, Life Science

Acadia Healthcare shares jump 9% after report it’s in talks with private equity firms

Life Science

Singlera Genomics and Fudan University unveil results showing Pan-Cancer Early Detection in the Taizhou Longitudinal Study

Life Science

Chi-Med Starts China Trials of Syk Inhibitor in Acute Myeloid Leukemia Patients

Life Science

SI-BONE Announces Pricing of Initial Public Offering at $15.00 per share

Life Science

Companies Team up to Accelerate Market Readiness of Drug Development Programs

Life Science

Alphamab Oncology’s HER2 bispecific antibody KN026 gained US IND approval; phase I clinical trial started in China

Life Science